Tag Archives: FWP

Top Medical Stocks To Buy Right Now

Smart investing isn’t just knowing what stocks to buy. It’s also knowing what stocks to avoid…

That’s why we’ve put together a list of stocks on death watch in 2016. While companies on this list aren’t guaranteed to fail, they have a high likelihood of doing so.

We’ll come out with a new stock death watch list every month, so be sure to check back often.

Here are three stocks on death watch in October 2016…

Death Watch Stocks, October 2016

Stocks on Death Watch No. 1: Valeant Pharmaceuticals International Inc. (NYSE: VRX)

Valeant is a drug company that makes both branded and generic drugs. It also makes certain medical devices, like contact lenses and surgical equipment. The company is known for its focus on distribution, rather than research and development, which former CEO Michael Pearson said makes it more efficient and profitable.

Top Medical Stocks To Buy Right Now: iShares 20+ Year Treasury Bond (TLT)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Nationwide Fund Advisors’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Nationwide+Fund+Advisors

    These are the top 5 holdings of Nationwide Fund AdvisorsiShares Core MSCI Emerging Markets (IEMG) – 4,698,924 shares, 74.25% of the total portfolio. Shares added by 119.53%iShares 20+ Year Treasury Bond ETF (TLT) – 536,574 shares, 17.7% of the total portfolio. Shares added by 79.94%iShares iBoxx $ High Yield Corporate Bond (HYG) – 347,518 shares, 8.05% of the total portfolio. Shares reduced by 20.57%

  • [By Dan Caplinger]

    In general, the longer a bond has until maturity, the more sensitive it is to interest rate movements. That has generally held true for Treasuries in 2018. The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT), which holds Treasury bonds with the longest maturities available, has seen its price fall 8% so far this year. Even when you take into account the income that bond ETFs provide, the iShares fund’s total return is still -7%.

  • [By Stephan Byrd]

    NEXT Financial Group Inc raised its position in Ishares Lehman 20 Year (NASDAQ:TLT) by 30.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,785 shares of the exchange traded fund’s stock after acquiring an additional 2,489 shares during the period. NEXT Financial Group Inc’s holdings in Ishares Lehman 20 Year were worth $1,315,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

  • [By Luke Kawa]

    All of these low-duration ETFs are trouncing their peers that carry a high degree of interest rate risk — like Vanguard’s Long-Term Bond ETF (BLV) and the iShares 20+ Year Treasury Bond ETF (TLT) — out of the gate in 2018.

Top Medical Stocks To Buy Right Now: Galmed Pharmaceuticals Ltd.(GLMD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s rankings:

    Get Galmed Pharmaceuticals alerts:

    Galmed Pharmaceuticals’ (GLMD) CEO Allen Baharaff on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) What You Must Know About Galmed Pharmaceuticals Ltds (NASDAQ:GLMD) Market Risks (finance.yahoo.com) Obeticholic Acid Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic … (theexpertconsulting.com) oholic Steatohepatitis (NASH) Market 2023: Know Marketing Channel Future Trend, Growth and Price with Future … (theexpertconsulting.com) Umbilical Cord Blood May Offer Early FH Diagnosis (medscape.com)

    A number of equities analysts have recently commented on GLMD shares. ValuEngine lowered shares of Galmed Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th. Maxim Group set a $14.00 price target on shares of Galmed Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, HC Wainwright lifted their price target on shares of Galmed Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a report on Monday, February 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $20.40.

  • [By Sean Williams]

    Similar strength was seen from microcap Galmed Pharmaceuticals (NASDAQ:GLMD), which rose by more than 150% during a single trading session two weeks ago despite mixed results. The move followed the release of phase 2b data from its 52-week Arrest study for NASH drug hopeful Aramchol. In that trial, a statistically significant reduction in liver fat was noted with one of the two doses (the 400 mg dose). However, the 600 mg dose led to a statistically significant improvement in overall NASH resolution (19.2% vs. 7.5%) and NASH resolution without worsening of fibrosis (16.7% vs. 5%) relative to the placebo.

  • [By Keith Speights]

    That’s exactly what happened this week with three small biotech stocks. Galmed Pharmaceuticals (NASDAQ:GLMD), Galectin Therapeutics (NASDAQ:GALT), and Eloxx Pharmaceuticals (NASDAQ:ELOX) soared on news that excited investors. Here’s what drove these stocks higher — and whether or not they’re smart picks for investors now.

  • [By George Budwell]

    Over the last two weeks, shares ofMadrigal Pharmaceuticals (NASDAQ:MDGL), Galmed Pharmaceuticals (NASDAQ:GLMD), and Viking Therapeutics (NASDAQ:VKTX) have more than doubled in value. The reason?

  • [By Jon C. Ogg]

    Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) was started as Outperform with a $26 price target at Raymond James on July 20, and that was versus a previous $15.02 closing price. A week earlier, onJune 13, Stifel Nicolaus initiated Galmed with a Buy rating and issued a $35 price target that would imply more than 100% upside. Galmed has been quite volatile as its 52-week range is listed at $3.61 to $27.06. It had a $322 million market cap as ofFriday. Galmed, which focuses on diseases and issues targeting the liver, closed at $15.00on Friday. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria.

  • [By George Budwell]

    Shares of the clinical-stage biotech Galmed Pharmaceuticals (NASDAQ:GLMD) are on absolute fire this morning, thanks to a positive midstage trial readout for its experimental nonalcoholic steatohepatitis (NASH) drug Aramchol. Specifically, the company reported that patients receiving the 400 mg dose of Aramchol exhibited a significant reduction in liver fat over the study period compared to those taking a placebo. Curiously, though, patients receiving the higher dose of 600 mg apparently only showed a statistically significant drop in liver fat relative to placebo patients in a post-hoc analysis, according to the press release.

Top Medical Stocks To Buy Right Now: Dril-Quip, Inc.(DRQ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Gabelli Funds LLC grew its holdings in Dril-Quip, Inc. (NYSE:DRQ) by 4.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,500 shares of the oil and gas company’s stock after purchasing an additional 2,500 shares during the period. Gabelli Funds LLC owned about 0.15% of Dril-Quip worth $2,486,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Solaris Oilfield Infrastructure (NYSE: SOI) and Dril-Quip (NYSE:DRQ) are both small-cap oils/energy companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Dril-Quip (DRQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Dril-Quip, Inc. (NYSE:DRQ) – Stock analysts at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for Dril-Quip in a research note issued on Monday, May 14th. Piper Jaffray analyst I. Macpherson anticipates that the oil and gas company will post earnings per share of ($0.11) for the quarter. Piper Jaffray currently has a “Hold” rating and a $40.00 price target on the stock. Piper Jaffray also issued estimates for Dril-Quip’s Q3 2018 earnings at ($0.08) EPS, Q4 2018 earnings at ($0.09) EPS, Q1 2019 earnings at ($0.03) EPS, Q2 2019 earnings at $0.02 EPS, Q3 2019 earnings at $0.08 EPS, Q4 2019 earnings at $0.08 EPS and FY2020 earnings at $0.64 EPS.

Top Medical Stocks To Buy Right Now: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Oasis Petroleum alerts:

    Oasis Petroleum CEO: Oil prices always come back to suppl… (finance.yahoo.com) Oasis Petroleum (OAS) Price Target Raised to $17.00 at JPMorgan Chase (americanbankingnews.com) Oasis Petroleum (OAS) Rating Increased to Overweight at Morgan Stanley (americanbankingnews.com) Oasis Petroleum (OAS) Given Buy Rating at Williams Capital (americanbankingnews.com) Oasis Petroleum (OAS) Forecasted to Post FY2018 Earnings of $0.44 Per Share (americanbankingnews.com)

    Several equities research analysts have recently commented on the stock. Stephens set a $15.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Tuesday, April 24th. Williams Capital reiterated a “buy” rating and set a $18.00 price target on shares of Oasis Petroleum in a research report on Wednesday. JPMorgan Chase & Co. set a $17.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Wednesday. Morgan Stanley upgraded shares of Oasis Petroleum from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $12.52 to $19.00 in a research report on Wednesday. Finally, BMO Capital Markets lifted their price target on shares of Oasis Petroleum from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, May 1st. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and sixteen have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $12.41.

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Benzinga News Desk]

    The curtain could come down any day on MoviePass’ bumpy run as an independent company: Link

    ECONOMIC DATA
    Chicago Fed national activity index +0.10 vs +0.27 expected
    The Composite Purchasing Managers' Index for April will be released at 9:45 a.m. ET.
    Existing home sales report for March is schedule for release at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    ANALYST RATINGS
    Deutsche Bank upgraded Michael Kors (NYSE: KORS) from Hold to Buy
    RBC downgraded Paylocity (NASDAQ: PCTY) from Outperform to Sector Perform
    Suntrust downgraded Oasis Petroleum (NYSE: OAS) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Ethan Ryder]

    Shares of Oasis Petroleum (NYSE:OAS) hit a new 52-week high and low during trading on Thursday . The company traded as low as $13.39 and last traded at $13.08, with a volume of 278190 shares traded. The stock had previously closed at $12.90.

  • [By Lee Jackson]

    Oasis Petroleum Inc. (NYSE: OAS) was downgraded to Hold from Buy at Jefferies, with a $14 price target. The Wall Street consensus target is set at $14.56. The shares closed trading on Friday at $12.86.

  • [By Jon C. Ogg]

    Oasis Petroleum Corp. (NYSE: OAS) was raised to Overweight from Equal Weight with a $19 target price (versus a $12.52 close) at Morgan Stanley.

    Old Dominion Freight Line Inc. (NASDAQ: ODFL) was started as Buy at Argus.

Top Medical Stocks To Buy Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Forward Pharma A/S (NASDAQ: FWP) fell 15.2 percent to $3.51 in pre-market trading after surging 88.18 percent on Tuesday.
    Pfenex Inc. (NASDAQ: PFNX) shares fell 15 percent to $5.85 in pre-market trading after the company announced an offering of common stock.
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) fell 17.6 percent to $47.75 in pre-market trading after the company reported downbeat results for its first quarter and issued a weak earnings forecast for the second quarter.
    Container Store Group, Inc. (NYSE: TCS) fell 13 percent to $7.15 in pre-market trading after reporting weaker-than-expected earnings for its fourth quarter.
    Ardelyx, Inc. (NASDAQ: ARDX) shares fell 12.1 percent to $4.00 in pre-market trading after reporting pricing of public offering of common stock.
    Boston Scientific Corporation (NYSE: BSX) shares fell 9.8 percent to $27.31 in pre-market trading.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 6.5 percent to $6.60 in pre-market trading.
    Target Corporation (NYSE: TGT) shares fell 5.8 percent to $71.02 in pre-market trading. Target reported weaker-than-expected earnings for its first quarter, while sales exceeded estimates.
    PBF Energy Inc. (NYSE: PBF) shares fell 5.7 percent to $42.42 in pre-market trading

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

Top Medical Stocks To Buy Right Now: Regions Financial Corporation(RF)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Regions Financial (RF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Regions Financial (NYSE:RF) from a hold rating to a buy rating in a report released on Wednesday.

    A number of other analysts also recently commented on RF. Keefe, Bruyette & Woods reiterated a neutral rating on shares of Regions Financial in a report on Sunday, April 22nd. B. Riley increased their price objective on shares of Regions Financial from $19.00 to $20.00 and gave the company a neutral rating in a report on Tuesday, April 24th. Three analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, five have issued a buy rating and two have given a strong buy rating to the company. Regions Financial has a consensus rating of Hold and an average price target of $17.56.

  • [By Shane Hupp]

    Regions Financial (NYSE:RF) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, July 20th. Analysts expect the company to announce earnings of $0.33 per share for the quarter.

  • [By ]

    Regions Financial (RF) : “I think this one is real good. I like the banks here.”

    Edwards Lifesciences (EW) : “They have the best devices. That stock is a buy.”

  • [By ]

    Regions Financial (NYSE: RF) could be a beneficiary of the move to deregulation in banking this year and is expected to grow earnings by 24% to $1.35 per share. The bank is seeing strong growth in non-interest income sources and management has a plan to cut up to 10% in operating expenses for greater profitability. Regions has a strong deposit base across the Southeast and averages a 7% return on equity, well above the industry average.

Top 5 High Tech Stocks To Watch Right Now

A Google Inc. Home device is displayed in front of YouTube Inc. signage during the company’s unveiling of a new television subscription service at the YouTube Space LA venue in Los Angeles, California, U.S., on Tuesday, Feb. 28, 2017. Photographer: Patrick T. Fallon/Bloomberg

Competition in the streaming TV market looks set to heat up, with Internet behemoth Google announcing that it will roll out a new service called YouTube TV in major cities in the United States over the next few months. AT&T, which became the largest U.S. pay TV provider in 2015 after its acquisition of DirecTV, is likely to be paying close attention to Google’s moves, as the carrier is betting big on its steaming TV offering – DirecTV Now – to mitigate the effects of a shrinking U.S. pay TV market. Below, we take a look at how Google’s upcoming offering compares and whether it poses a legitimate threat to AT&T and other players.

Top 5 High Tech Stocks To Watch Right Now: Internap Network Services Corporation(INAP)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 28 percent to $2.32 as the company reported that it has raised $43 million in a common equity private placement.

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

Top 5 High Tech Stocks To Watch Right Now: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top 5 High Tech Stocks To Watch Right Now: SORL Auto Parts Inc.(SORL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) shares shot up 19 percent to $7.15 after the company reported strong results for its third quarter and raised its FY17 outlook. The company reported Q3 EPS of 44 cents, up from 17 cents in the same quarter of last year. The company reported sales of $101.33 million, up from $63.7 million in the same quarter of last year.

  • [By ]

    1. Sorl Auto Parts (Nasdaq: SORL)
    Shares of this Chinese automobile brake and safety equipment maker are setting up to be an ideal breakout candidate. Sorl supplies automobile brakes and safety equipment to over 75 original equipment manufacturers, most of them in China.

Top 5 High Tech Stocks To Watch Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

Top 5 High Tech Stocks To Watch Right Now: Big 5 Sporting Goods Corporation(BGFV)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Dick’s Sporting Goods (NYSE:DKS) and Big 5 Sporting Goods (NASDAQ:BGFV) have both had a great 2016. As far as stock performance goes, Big 5 is the winner this year. But which company is in better shape for the new year?

stock quotes today

Wells Fargo’s Bonnie Herzog and team argue that Starbucks’ (SBUX) partnership withAnheuser-Busch InBev (BUD) to bottle and sell tea will “transform the tea market much like Starbucks did with coffee.” They explain:

Zuma Press

StarbucksTo Enter Fast Growing, Premium Ready-to-Drink (RTD) Category withAnheuser Busch Inbev Partnership Starbucks announced late yesterday that it expects to finalize a definitive agreement with Anheuser-Busch by 2H16 to jointly produce, bottle, distribute and market the first RTD version of Teavana in the U.S. with an initial launch expected in the 1H17. We view this as a significant opportunity forStarbucks to extend its reach into one of the fastest growing RTD segments, the premium RTD tea category, which while a small part of the $125B global tea industry, is growing in the mid-teens with annual sales at $1.1B. GivenStarbucks’ expertise in teas and the sheer reach of Anheuser-Buschs distribution network, we estimateStarbucks could take ~25-30% share of the RTD premium tea segment within the first full year (FY18E), driving an incremental $200-250M in revenue and approximately $0.03-0.04 of EPS, or ~1-2% of incremental growth. Bottom line We believeAnheuser-Busch will make an exceptional DSD partner that will expand a valuable route-to-market forStarbucks and transform the tea market much likeStarbucks did with coffee.

stock quotes today: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

stock quotes today: Cabot Oil & Gas Corporation(COG)

Advisors’ Opinion:

  • [By David Sterman]

    Take Cabot Oil & Gas (NYSE: COG(link is external)) as an example. As I noted earlier this month(link is external), Cabot’s current drilling plans are expected to lead to a big spike in output over the next few years. The company’s executives decided to plow ahead with development plans, even as rivals were retrenching. The fact that natural gas prices have risen more than 10% in the past three weeks simply underscores the wisdom of that strategy, and could lead to rising sales and profit estimates. 

  • [By Paul Ausick]

    Cabot Oil & Gas Corp. (NYSE: COG) is rated as a Hold with a new price target of $24. The EPS estimate has been cut from $0.60 to $0.47 for 2017, and the 2018 estimate has been increased from $0.70 to $1.19. Shares closed at $22.36 on Friday in a 52-week range of $19.77 to $25.74. The consensus 12-month price target is $28.72.

stock quotes today: PHI, Inc.(PHIIK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap offshore oil and gas services stock PHI Inc (NASDAQ: PHIIK):

    We’re a little bit late to the party here, but that’s ok – there’s still some meat left on the bone, so to speak. Were looking for the stock to continue on to the lower edge of a long-term (and bearish) trading range that should allow it to peel back to at least the lower $12’s. We’ve see PHIIK shares tumble with great speed and distance a couple of times already, and we’re about halfway through round three.

stock quotes today: Fiesta Restaurant Group, Inc.(FRGI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Chipotle Mexican Grills shares back to breakeven while of the small caps peers, El Pollo LoCo Holdings Inc (NASDAQ: LOCO) has had the worst performance, Fiesta Restaurant Group Inc (NASDAQ: FRGI) is off its 2015s peak and Chuy’s Holdings Inc (NASDAQ: CHUY) has been a mixed performer:

  • [By Peter Graham]

    A long term performance chart shows Del Taco Restaurants now outperforming Mexican restaurant stock peers such as mid cap Chipotle Mexican Grill, Inc (NYSE: CMG) and small caps El Pollo LoCo Holdings Inc (NASDAQ: LOCO), Fiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY) have mostly been drifting lower lately:

  • [By Lisa Levin]

    Fiesta Restaurant Group Inc (NASDAQ: FRGI) shares dropped 24 percent to $19.83. Fiesta Restaurant posted in-line Q4 earnings, but sales missed estimates. The company also disclosed that it has suspended its sale exploration process and appointed a new CEO. Raymond James downgraded Fiesta Restaurant from Outperform to Market Perform.

  • [By Peter Graham]

    A long term performance chart shows El Pollo LoCo Holdings stabilizing over thepast two yearswhile potentialpeers like large cap Chipotle Mexican Grill, Inc (NYSE: CMG) andsmall capsFiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY)have performed better in the past and appear to be in downtrends for the past 1 1/2 years:

define investment

Earlier this year, I wrote an article entitled Brazil: If We’re Really Doomed To Repeat History, I’m Buying, in which I presented the case that events were setting themselves up in a way that was eerily similar to 2002, just before the economy turned around and the equity market would go on to post multiple years of strong returns. Since then, the (NYSEARCA:EWZ) ETF is up around 20%, and there have been some additional data points and developments that have motivated me to provide an update to the country’s prospects. Many of the country’s fundamentals now point to it already being in the initial phase of a recovery, however the ongoing political turmoil, which has since seen the impeachment of president Dilma Rousseff, could prove a difficult source of “unknown unknowns” that hold back further investment inflows.

First of all, the stagflationary trends presented in the previous analysis have started a reversal. GDP, while still negative, has improved, and inflation has continued to fall after peaking at the end of last year. All of this is again remnant of early 2003, which marked a period of years of healthy equity returns:

define investment: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By James E. Brumley]

    Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

    Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

    And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

    It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

    It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

    In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

    It’s a rather amazing science, really. Radient Technologies uses an ingredient-extraction process called microwave assisted proc

  • [By Bryan Murphy]

    It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

    Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

    Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

    To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.

    Using its patented MAP process, Radient is able to selectiv

  • [By Jim Robertson]

    Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

define investment: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By Monica Gerson] Related CSC Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Computer Sciences' (CSC) CEO Mike Lawrie on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise … (GuruFocus)

    Some of the stocks that may grab investor focus today are:

  • [By R. Chandrasekaran]

    Some of the outperforming stocks:

    NVDIA Corp (NASDAQ: NVDA) trading up about 5.7 percent with a range between $69.50 and $71.72.
    Amazon.com, Inc. (NASDAQ: AMZN) is gaining about 4 percent. The stock ranged between $770.94 and $787.73.
    Computer Sciences Corporation (NYSE: CSC) is gaining about 3.3 percent with the stock trading between $56.10 and $58.01.
    Microsoft Corporation (NASDAQ: MSFT) is adding about 3 percent with the stock ranging $59.78-$60.52.
    Alphabet Inc (NASDAQ: GOOGL) is gaining about 2.9 percent with the stock trading between $792.90 and $805.
    Intel Corporation (NASDAQ: INTC) is adding approximately 2.9 percent with shares trading in the range of $34.15-$34.60.
    Cisco Systems, Inc. (NASDAQ: CSCO) is gaining about 2.8 percent as the stock traded between $30.61 and $31.05.
    Salesforce.com, inc. (NYSE: CRM) is adding about 2.8 percent with the shares traded in the range of $75.41-$77.00

define investment: Atlantia S.p.A. (ATASF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

define investment: Lincoln National Corporation(LNC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

  • [By Lee Jackson]

    Lincoln National Corp. (NYSE: LNC) also had the man at the top selling stock last week. Dennis Glass, the CEO of this insurance and retirement focused company, sold a block of 75,000 shares at between $71.00 and $71.28 apiece. The total for the sale was posted at $5 million. Shares closed Friday at $71.69, in a 52-week rangeof $34.16 to $73.71. The consensus price target is $73.17.

define investment: Fiesta Restaurant Group, Inc.(FRGI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Chipotle Mexican Grills shares back to breakeven while of the small caps peers, El Pollo LoCo Holdings Inc (NASDAQ: LOCO) has had the worst performance, Fiesta Restaurant Group Inc (NASDAQ: FRGI) is off its 2015s peak and Chuy’s Holdings Inc (NASDAQ: CHUY) has been a mixed performer:

  • [By Peter Graham]

    A long term performance chart shows Del Taco Restaurants now outperforming Mexican restaurant stock peers such as mid cap Chipotle Mexican Grill, Inc (NYSE: CMG) and small caps El Pollo LoCo Holdings Inc (NASDAQ: LOCO), Fiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY) have mostly been drifting lower lately:

  • [By Lisa Levin]

    Fiesta Restaurant Group Inc (NASDAQ: FRGI) shares dropped 24 percent to $19.83. Fiesta Restaurant posted in-line Q4 earnings, but sales missed estimates. The company also disclosed that it has suspended its sale exploration process and appointed a new CEO. Raymond James downgraded Fiesta Restaurant from Outperform to Market Perform.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

define investment: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

bombay stock exchange

Blackstone co-founder Stephen Schwarzman (Photograph by Jamel Toppin)

As President Donald Trump visits Saudi Arabia on the biggest foreign trip of his presidency, private equity giant Blackstone Group is unveiling a $40 billion infrastructure fund with the gulf nation, which will primarily invest in the United States. Saudi Arabia will commit $20 billion to the Blackstone infrastructure fund and another $20 billion will be raised from other limited partners, readying cash that could lead to $100 billion in total infrastructure investments on a leveraged basis.

Blackstone, co-founded by billionaire Stephen Schwarzman, head of Trump’s business council, said on Saturday morning the fund effectively launches a new business line for the over $360 billion in assets firm. Already a powerhouse in private equity, real estate, hedge funds and credit investments, Blackstone has been preparing for a push into infrastructure, spotting an opportunity as large investors increasingly plant their money into the cogs of the global economy such as buildings, ports, wireless infrastructure, pipelines, railroads and airports.

bombay stock exchange: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology shares gained around 0.85 percent in trading on Friday. Meanwhile, top gainers in the sector included Virtusa Corporation (NASDAQ: VRTU), and Ceragon Networks Ltd (NASDAQ: CRNT).

bombay stock exchange: Expeditors International of Washington, Inc.(EXPD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

    PACCAR Inc (NASDAQ: PCAR) Aug16 52.5 Puts: 10000 @ ASK $1.70: 10k traded vs 335 OI: Earnings 7/26 $54.94 Ref
    Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Jul16 345 Puts: 949 @ ASK $8.70: 1003 traded vs 55 OI: Earnings 8/2 $360.20 Ref
    NVIDIA Corporation (NASDAQ: NVDA) Fri 6/24 47.0 Puts (Wkly) Sweep: 689 @ ASK $1.12: 3758 traded vs 136 OI: Earnings 8/4 $46.69 Ref
    Medivation Inc (NASDAQ: MDVN) Sep16 55.0 Puts: 4000 @ Above Ask! $3.40: 5303 traded vs 716 OI: Earnings 8/4 $59.44 Ref
    Expeditors International of Washington (NASDAQ: EXPD) Aug16 47.0 Puts Sweep: 950 @ ASK $1.35: 973 traded vs 381 OI: Earnings 8/2 $48.15 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

bombay stock exchange: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

bombay stock exchange: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Ben Levisohn]

    Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.

    Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.

  • [By Lisa Levin]

    Francesca's Holdings Corporation (NASDAQ: FRAN) was down, falling around 9 percent to $7.09 following downbeat quarterly earnings.

    Commodities

bombay stock exchange: Formula Systems (1985) Ltd.(FORTY)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, technology shares rose by 0.26 percent. Meanwhile, top gainers in the sector included Applied Materials, Inc. (NASDAQ: AMAT), up 9 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY) up 19 percent.

  • [By Lisa Levin]

    In trading on Thursday, technology shares fell by 0.32 percent. Meanwhile, top losers in the sector included Mitek Systems, Inc. (NASDAQ: MITK), down 13 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY), down 8 percent.